Status:
TERMINATED
Neoadjuvant Chemotherapy in Non Small Cell Lung Cancer (NSCLC) Stages IB, IIA, IIB, and IIIA/T3
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
Randomised trial of chemotherapy or not before surgery in early resectable stages of NSCLC (IB, IIA, IIB, and IIIA/N2).
Detailed Description
Randomisation between 3 courses of neoadjuvant Carboplatin plus Paclitaxel or no chemotherapy before surgery.
Eligibility Criteria
Inclusion
- NSCLC
- Stages IB, IIA, IIB, IIIA/T3
- Lung function test allowing surgery
- Age 18-75 years
Exclusion
- Poor lung function
- Performance status 3-4
- Mediastinal lymph node involvement
Key Trial Info
Start Date :
January 1 1998
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
270 Patients enrolled
Trial Details
Trial ID
NCT00273507
Start Date
January 1 1998
End Date
January 1 2006
Last Update
September 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. Oncology, Rigshospitalet
Copenhagen, Copenhagen, Denmark, 2100